95 related articles for article (PubMed ID: 4086924)
21. Comparison of cytogenetic abnormalities and deoxyribonucleic acid ploidy of benign, borderline malignant, and different grades of malignant soft tissue tumors.
Van den Berg E; Van Oven MW; de Jong B; Dam A; Wiersema J; Dijkhuizen T; Hoekstra HJ; Molenaar WM
Lab Invest; 1994 Mar; 70(3):307-13. PubMed ID: 8145525
[TBL] [Abstract][Full Text] [Related]
22. Mast cell and lymphoreticular infiltrates in neurofibromas. Comparison with nerve sheath tumors.
Johnson MD; Kamso-Pratt J; Federspiel CF; Whetsell WO
Arch Pathol Lab Med; 1989 Nov; 113(11):1263-70. PubMed ID: 2479359
[TBL] [Abstract][Full Text] [Related]
23. What are the CD34+ cells in benign peripheral nerve sheath tumors? Double immunostaining study of CD34 and S-100 protein.
Khalifa MA; Montgomery EA; Ismiil N; Azumi N
Am J Clin Pathol; 2000 Jul; 114(1):123-6. PubMed ID: 10884807
[TBL] [Abstract][Full Text] [Related]
24. The controversial nosology of benign nerve sheath tumors: neurofilament protein staining demonstrates intratumoral axons in many sporadic schwannomas.
Nascimento AF; Fletcher CD
Am J Surg Pathol; 2007 Sep; 31(9):1363-70. PubMed ID: 17721192
[TBL] [Abstract][Full Text] [Related]
25. Pathologic classification of peripheral nerve tumors.
Skovronsky DM; Oberholtzer JC
Neurosurg Clin N Am; 2004 Apr; 15(2):157-66. PubMed ID: 15177315
[TBL] [Abstract][Full Text] [Related]
26. Expression of emmprin and matrix metalloproteinases (MMPs) in peripheral nerve sheath tumors: emmprin and membrane-type (MT)1-MMP expressions are associated with malignant potential.
Nabeshima K; Iwasaki H; Nishio J; Koga K; Shishime M; Kikuchi M
Anticancer Res; 2006; 26(2B):1359-67. PubMed ID: 16619545
[TBL] [Abstract][Full Text] [Related]
27. [Cytofluorometric analysis of cell kinetics in relation to tumor growth of advanced gastric cancers].
Kamachi M; Morotomi N; Fujimoto T; Fujimiya T; Okabe H; Tsuchihashi Y; Kodama M; Takeoka O; Ashihara T
Gan No Rinsho; 1984 Nov; 30(14):1759-66. PubMed ID: 6513029
[TBL] [Abstract][Full Text] [Related]
28. Tumors of the brachial plexus.
Lusk MD; Kline DG; Garcia CA
Neurosurgery; 1987 Oct; 21(4):439-53. PubMed ID: 3317105
[TBL] [Abstract][Full Text] [Related]
29. Malignant peripheral nerve tumors: a clinicopathological and electron microscopic study.
Arpornchayanon O; Hirota T; Itabashi M; Nakajima T; Fukuma H; Beppu Y; Nishikawa K
Jpn J Clin Oncol; 1984 Mar; 14(1):57-74. PubMed ID: 6423867
[TBL] [Abstract][Full Text] [Related]
30. Neoplasms of the peripheral nervous system.
Potter GK; Feldman JS
Clin Podiatr Med Surg; 1990 Jan; 7(1):141-9. PubMed ID: 2105831
[TBL] [Abstract][Full Text] [Related]
31. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
32. Solitary cutaneous plexiform neurilemmoma (schwannoma): a clinicopathologic, immunohistochemical, and ultrastructural study of 11 cases.
Kao GF; Laskin WB; Olsen TG
Mod Pathol; 1989 Jan; 2(1):20-6. PubMed ID: 2493641
[TBL] [Abstract][Full Text] [Related]
33. Peripheral nerve sheath tumors. A clinicopathologic update.
Fletcher CD
Pathol Annu; 1990; 25 Pt 1():53-74. PubMed ID: 2404250
[No Abstract] [Full Text] [Related]
34. The ultrastructure of schwannoma and neurofibroma of the peripheral nerves.
Sanguinetti C; Greco F; de Palma L; Specchia N; Toesca A; Nori S
Ital J Orthop Traumatol; 1991 Jun; 17(2):237-46. PubMed ID: 1797735
[TBL] [Abstract][Full Text] [Related]
35. Mediastinal tumors of peripheral nervous system origin.
Marchevsky AM
Semin Diagn Pathol; 1999 Feb; 16(1):65-78. PubMed ID: 10355655
[TBL] [Abstract][Full Text] [Related]
36. Mast cells in benign nerve sheath tumours.
Isaacson P
J Pathol; 1976 Aug; 119(4):193-6. PubMed ID: 822142
[TBL] [Abstract][Full Text] [Related]
37. Preliminary study regarding the utility of certain immunohistochemical markers in diagnosing neurofibromas and schwannomas.
Ghiluşi M; Pleşea IE; Comănescu M; Enache SD; Bogdan F
Rom J Morphol Embryol; 2009; 50(2):195-202. PubMed ID: 19434310
[TBL] [Abstract][Full Text] [Related]
38. Lipocortin-1 immunoreactivity in central and peripheral nervous system glial tumors.
Johnson MD; Kamso-Pratt J; Pepinsky RB; Whetsell WO
Hum Pathol; 1989 Aug; 20(8):772-6. PubMed ID: 2526074
[TBL] [Abstract][Full Text] [Related]
39. Malignant peripheral nerve sheath tumors with divergent differentiation.
Ducatman BS; Scheithauer BW
Cancer; 1984 Sep; 54(6):1049-57. PubMed ID: 6432304
[TBL] [Abstract][Full Text] [Related]
40. Malignant peripheral nerve-sheath tumors (malignant schwannomas). An immunohistochemical study of 29 cases.
Daimaru Y; Hashimoto H; Enjoji M
Am J Surg Pathol; 1985 Jun; 9(6):434-44. PubMed ID: 3937453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
